TMDX Q1 2025 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$144M+48.2% YoY

Gross Profit

$88M61.5% margin

Operating Income

$27M19.1% margin

Net Income

$26M17.9% margin

EPS (Diluted)

$0.70

QoQ Revenue Growth

+18.0%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$30M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$838M

Total Liabilities

$571M

Stockholders' Equity

$266M

Cash & Equivalents

$310M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$144M	$97M	+48.2%
Gross Profit	$88M	$60M	+47.4%
Operating Income	$27M	$12M	+120.9%
Net Income	$26M	$12M	+110.6%

Revenue Segments

Product

$88M61%

Service

$55M39%